Accretion Nutraveda Limited, formerly known as Accretion Nutraveda Private Limited, announced that its shareholders approved an alteration to the company's object clause on October 9, 2026, following a postal ballot held on September 1, 2026. The revised clause expands the company's business scope to include a wider range of nutraceuticals, dietary supplements, pharmaceuticals, cosmetics, medical equipment, and related activities, as well as investments and acquisitions.